LDLR and glioma: The resulting functionalized EVs (EVs-KLA-LDL) significantly enhanced the process of low-density lipoprotein receptor (LDLR)-mediated internalization both in vitro and in vivo, improving the delivery of the proapoptotic peptide KLA and methotrexate (MTX) to U87 glioma cells [150].